Vitamin D supplementation for cardiometabolic risk markers in pregnant women based on the gestational diabetes mellitus or obesity status : a randomized clinical trial
European Journal of Nutrition · 2024-10 · 63 (7) · 2599-2609
DOI: 10.1007/s00394-024-03443-6 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Nutrition, online erschienen am 15.06.2024. Verfasst von Wan-Jun Yin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Joint Research Center of Occupational Medicine and Health, Institute of Grand Health, Hefei Comprehensive National Science Center, Anhui University o…. Hauptthemen laut MEDLINE: Diabetes, Gestational, Dietary Supplements, Vitamin D, Obesity. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
PURPOSE: Women with gestational diabetes mellitus (GDM) or obesity are vulnerable to impaired gestational cardiovascular health (CVH) and cardiovascular disease (CVD) in the future. It is unclear if prenatal vitamin D supplementation improves gestational CVH, especially in women at high risk for developing CVD. Our goal was to find out if vitamin D supplementation could protect against gestational CVH, including the women with GDM or obesity. DESIGN: We randomly assigned women with a serum 25(OH)D concentration < 75 nmol/L to receive 1600 IU/d (intervention group) or 400 IU/d (control group) of vitamin D3 for two months at 24-28 weeks' gestation. The primary outcome was gestational CVH marks (lipids, inflammatory cytokines, endothelial function). RESULTS: There were 1537 participants divided into the intervention (N = 766) and control groups (N = 771). No baseline differences existed among study groups in CVH markers. At the two-month visit, the intervention group's HDL-C levels (2.01 ± 0.39 VS 1.96 ± 0.39 mmol/L) were significantly higher than those of the control group, while the hs-CRP levels were significantly lower (3.28 ± 2.02 VS 3.64 ± 2.42 mg/L). Subgroup analysis found that HDL-C, TC, hs-CRP, E-Selectin, and SBP were improved in the intervention group among women with GDM or overweight/obesity, and the improvement was not found in women without GDM or overweight/obesity. Vitamin D supplementation significantly decreased the mean triglyceride-glucose index at the two-month visit in women with GDM. CONCLUSIONS: Vitamin D supplementation at mid-gestation might optimize the gestational CVH status for pregnant women, particularly the women with GDM or obesity, which is advantageous for later-life primary prevention of CVD. CLINICAL TRIAL REGISTRATION: The Chinese Clinical Trial Registry (ChiCTR2100051914, 10/9/2021, Prospective registered, https://www.chictr.org.cn/showproj.aspx?proj=134700 ).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joint Research Center of Occupational Medicine and Health, Institute of Grand Health, Hefei Comprehensive National Science Center, Anhui University of Science and Technology, Hefei, China.
- School of public health, Anhui University of Science and Technology, Hefei, China.
- Department of Maternal, Child & Adolescent Health, School of Public Health, Anhui Medical University, Hefei, China.
- MOE Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Hefei, 230032, China.
- Key Laboratory of Industrial Dust Prevention and Control, Occupational Safety and Health, Ministry of Education, Anhui University of Science and Technology, Hefei, China.
- Department of Obstetrics and Gynecology, Hefei First People's Hospital, Hefei, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yin, W. J., Wang, P., Ma, S. S., Tao, R. X., Hu, H. L., Jiang, X. M., Zhang, Y., Tao, F. B., & Zhu, P. (2024). Vitamin D supplementation for cardiometabolic risk markers in pregnant women based on the gestational diabetes mellitus or obesity status : a randomized clinical trial. European Journal of Nutrition, 63(7), 2599-2609. https://doi.org/10.1007/s00394-024-03443-6
Vancouver
Yin WJ, Wang P, Ma SS, Tao RX, Hu HL, Jiang XM, et al. Vitamin D supplementation for cardiometabolic risk markers in pregnant women based on the gestational diabetes mellitus or obesity status : a randomized clinical trial. European Journal of Nutrition. 2024;63(7):2599-2609. doi:10.1007/s00394-024-03443-6
BibTeX
@article{Yin2024,
author = {Yin, Wan-Jun and Wang, Peng and Ma, Shuang-Shuang and Tao, Rui-Xue and Hu, Hong-Lin and Jiang, Xiao-Min and Zhang, Ying and Tao, Fang-Biao and Zhu, Peng},
title = {Vitamin D supplementation for cardiometabolic risk markers in pregnant women based on the gestational diabetes mellitus or obesity status : a randomized clinical trial},
journal = {European Journal of Nutrition},
year = {2024},
volume = {63},
number = {7},
pages = {2599--2609},
doi = {10.1007/s00394-024-03443-6}
}
EUVIMED